Navigation Links
Southwest Oncology Network (SWON) Selects Diplomat Specialty Pharmacy for Development and Launch of SWON-Rx, an Oral Oncology Medication Management Platform
Date:5/18/2010

SWARTZ CREEK, Mich., May 18 /PRNewswire/ -- Diplomat Specialty Pharmacy (Diplomat), the largest privately owned specialty pharmacy in the country, announced today that effective May 11, 2010, they have entered into a joint agreement with Southwest Oncology Network (SWON) to create SWON-Rx, a comprehensive specialty pharmacy support program to help practices manage oral oncology medications.  SWON-Rx will create programs that support SWON members' efforts to achieve optimal clinical outcomes for their patients.    

SWON is a professional limited liability company whose members are physicians and physician practices whose patients routinely require high-cost, specialty pharmaceuticals specifically for treatment of cancer.  SWON currently consists of 65 oncology practices throughout the United States, representing approximately 272 oncologists.

The joint agreement between SWON and Diplomat will provide SWON members access to Diplomat's Oncology Navigator™ program.  The Oncology Navigator™ Program incorporates over 35 years of experience in providing clinical and reimbursement solutions to patients with oncologic and hematologic disorders.  

"SWON selected Diplomat because of their patient centric reputation in the industry, their high level of customer service, and their commitment to helping oncology patients get the medications they need to obtain optimal clinical outcomes," stated  Mark Colangelo, SWON Vice President.  "Diplomat has unique expertise and dedicated resources that assist patients in reducing the financial burdens associated with these life-sustaining medications. SWON member practices value the support this provides their patients and their staff."


'/>"/>
SOURCE Diplomat Specialty Pharmacy
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System
2. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
3. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
6. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
7. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
8. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
9. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
10. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
11. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... ® Technologies, Inc., the leader in non-invasive, accelerated orthodontic ... to continued demand from orthodontists and patients for safe, ... locations in the U.S. and Canada ... the only FDA-cleared Class II medical device that has ... much as 50 percent.  A recent ...
(Date:5/26/2015)... NEW YORK , May 26, 2015 /PRNewswire/ ... that Jennifer Simpson , Ph.D., M.S.N., C.R.N.P. ... by the Company,s Board of Directors, effective immediately.  ... Chief Executive Officer of Delcath since September 2014 ... from September 2013 to September 2014.  She joined ...
(Date:5/26/2015)... 26, 2015  LabStyle Innovations Corp. (DRIO), ... announced today that in partnership with ... Healthcare, it has launched  the comprehensive Dario™ ... advanced Telecare unit (MOMA). The Dario™ is ... enables remote treatment for diabetes aiming to ...
Breaking Medicine Technology:OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 3Delcath Names Dr. Jennifer Simpson President And CEO 2Delcath Names Dr. Jennifer Simpson President And CEO 3Delcath Names Dr. Jennifer Simpson President And CEO 4LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 2LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 3LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 4
... study broadens Phase 3 clinical program to further evaluate the ... April 15 Pfizer (NYSE: PFE ) and ... announced the initiation of a 12-month, Phase 3 clinical trial ... CONCERT, is designed to evaluate the safety and efficacy of ...
... Pharmacyclics, Inc.,(Nasdaq: PCYC ) today announced that ... study to evaluate the safety and tolerability of PCI-32765,an ... Btk,as a potential treatment for patients with relapsed or ... first Btk selective inhibitor to,be tested in humans, and ...
Cached Medicine Technology:Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 2Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 3Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 4Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 2Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 3Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 4Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 5
(Date:5/26/2015)... Neeta Pai was diagnosed with HHT ... spells, four of which landed her in the emergency ... , Though she still struggles with anemia, iron deficiency ... time to increasing HHT awareness and garnering support for ... we could have prevented all the heartbreak and trauma ...
(Date:5/26/2015)... Sexual harassment and sexual assault are major ... known for creating opportunities in women's athletics, it is now ... and prevention. In a recent episode of SCI TV ... explains what Title IX means for university administrators dealing with ... this issue to protect students. , In the last 15 ...
(Date:5/26/2015)... senior industry executives are expected at the Suburban Collection ... connected car. A very special attraction for the clear-headed ... driver’s brain waves. Visitors to its booth will be ... just by gripping the steering wheel! , Peter Freer, ... cognitive load, altering music based on the driver’s mood, ...
(Date:5/26/2015)... 26, 2015 Relias Learning , ... the health and human services market, announces expansion of ... After strong attendance and participation in 2014, they will ... their annual user conference an exciting new facelift. ... come together and discuss best practices, share their expertise, ...
(Date:5/26/2015)... Mr. Larry Westenberg is a Licensed ... Programming, or NLP. Mr. Westenberg is recently also ... or RRT®. While many people have learned small ... to specific areas, Mr. Westenberg has been studying the ... years. He works with people suffering the effects ...
Breaking Medicine News(10 mins):Health News:Rochester Woman Brings Awareness to Genetic Disease 2Health News:Paul Greene Explores Title IX and College Sports on SCI TV 2Health News:Paul Greene Explores Title IX and College Sports on SCI TV 3Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3
... Re-elect Directors, Ratify E&Y and Approve Charter Amendment; ... Board Re-appoints Leadership, ... the "Company") said today that its Board of Directors declared,a regular ... 2008 to stockholders of record on June 4, 2008. The dividend ...
... Calif., May 19 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... S.,Williams has rejoined the company in a ... a wholly owned subsidiary of Alexza. Mr.,Williams ... Alexza,subsidiary in Singapore and establishing potential joint ...
... VALLEY FORGE, Pa., May 19 The St. Jude ... first drywall ever manufactured at the,new CertainTeed Gypsum Plant ... for St. Jude Children,s Research Hospital, CertainTeed is,donating gypsum ... the,house., (Logo: http://www.newscom.com/cgi-bin/prnh/20070102/CLTU053LOGO ), The ...
... Provides Development Expertise for Partners ... Developing on the Google Health Platform, PORTLAND, Ore., May ... and development company, announced,collaboration today with Google as a development ... to the public at an,event at Google,s headquarters today; the ...
... Program seeks to advance knowledge of mysterious conditions , , ... program designed to help patients with mysterious health conditions ... U.S. National Institutes of Health. , The Undiagnosed Diseases ... to the NIH Clinical Center by doctors across the ...
... of Nebraska Medical Center-led pilot study that showed antidepressants ... and neck cancer patients is the focus of an ... one of the publications produced by the Journal of ... led by UNMCs William Lydiatt, M.D., and Bill Burke, ...
Cached Medicine News:Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 2Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 3Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 4Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 5Health News:Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd. 2Health News:Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd. 3Health News:Gypsum Wallboard from CertainTeed's Moundsville, W. Va., Plant and Roofing Shingles among Building Materials Donated to St. Jude Dream Home(R) 2Health News:Mount Tabor Collaborates with Google Health 2Health News:U.S. Turns Spotlight on Medicine's Most Puzzling Cases 2Health News:JAMA publication features study on depression and head and neck cancer 2
... data for future generations. Most gels can be ... plate of our gel dryer, covering them with ... them to hold the cellophane flat. Tut's Tombs ... an open area somewhat larger than the gel ...
... Most gels can be dried by positioning them ... dryer, covering them with wet semi-permeable cellophane and ... cellophane flat. Tut's Tombs also produce great fluorographs. ... larger than the gel to be dried. Note ...
... Hoefer SE 1200 Easy Breeze Air Gel ... 25 cm or 24 gels 8 ... warm air temperatures for rapid drying, or no ... photograph or store smooth, transparent, dried gels. Add ...
... Gel Dryer : Dry up to 6 gels ... 10 cm without a vacuum pump. Choose ... no heat for controlled drying of problem gels. ... Add and remove gels at any time without ...
Medicine Products: